Showing results (11-20 of 69) with videos related to
Sort By:
Pageof 7
The Journal of Physical Chemistry Letters|October 21, 2020
Thermodynamics of the Interaction between the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus-2 and the Receptor of Human Angiotensin-Converting Enzyme 2. Effects of Possible LigandsCristina García-Iriepa, Cécilia Hognon, Antonio Francés-Monerris, et al.Chemical Record (New York, N.Y.)|November 10, 2020
Tacrines as Therapeutic Agents for Alzheimer's Disease. V. Recent DevelopmentsÓscar M Bautista-Aguilera, Lhassane Ismaili, Isabel Iriepa, et al.The Science of the Total Environment|June 4, 2017
Dendrimer-functionalized electrospun nanofibres as dual-action water treatment membranesGeorgiana Amariei, Javier Santiago-Morales, Karina Boltes, et al.Current Alzheimer Research|October 30, 2019
Synthesis and Biological Evaluation of Novel Chromone+Donepezil Hybrids for Alzheimer's Disease TherapyRim Malek, Bernard Refouvelet, Mohamed Benchekroun, et al.The Journal of Pharmacology and Experimental Therapeutics|January 23, 2003
Effects of irbesartan on cloned potassium channels involved in human cardiac repolarizationIgnacio Moreno, Ricardo Caballero, Teresa González, et al.Bioorganic Chemistry|July 8, 2015
Harmaline and hispidin from Peganum harmala and Inonotus hispidus with binding affinity to Candida rugosa lipase: In silico and in vitro studiesKhedidja Benarous, Isabelle Bombarda, Isabel Iriepa, et al.European Journal of Medicinal Chemistry|October 20, 2012
Pyridonepezils, new dual AChE inhibitors as potential drugs for the treatment of Alzheimer's disease: synthesis, biological assessment, and molecular modelingAbdelouahid Samadi, Martín Estrada, Concepción Pérez, et al.Future Medicinal Chemistry|May 16, 2017
Synthesis and biological assessment of racemic benzochromenopyrimidinetriones as promising agents for Alzheimer's disease therapyYoussef Dgachi, Helène Martin, Alexandre Bonet, et al.International Journal of Molecular Sciences|February 13, 2025
2-{N-[ω-(1-Benzylpiperidin-4-yl)alkyl]amino}-6-[(prop-2-yn-1-yl)amino]pyridine-3,5-dicarbonitriles Showing High Affinity for σ1/2 ReceptorsWinnie Deuther-Conrad, Dirk Schepmann, Isabel Iriepa, et al.European Journal of Medicinal Chemistry|July 11, 2013
Synthesis, pharmacological assessment, and molecular modeling of 6-chloro-pyridonepezils: new dual AChE inhibitors as potential drugs for the treatment of Alzheimer's diseaseAbdelouahid Samadi, Mario de la Fuente Revenga, Concepción Pérez, et al.Pageof 7